Nutex Health (NUTX) Cash from Financing Activities (2012 - 2026)

Nutex Health (NUTX) has 14 years of Cash from Financing Activities data on file, last reported at -$49.5 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 627.38% year-over-year to -$49.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$140.7 million (down 1133.33% YoY) and the FY2025 annual result came in at -$97.9 million, down 9077.91% from the prior year.
• Cash from Financing Activities slipped to -$49.5 million in Q1 2026 per NUTX's latest filing, from -$45.8 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $5.7 million in Q1 2024, with the low at -$49.5 million in Q1 2026.
• Average Cash from Financing Activities over 5 years is -$11.6 million, with a median of -$4.3 million recorded in 2023.
• Year-over-year, Cash from Financing Activities sank 7144.95% in 2022 and soared 137.74% in 2023.
• Nutex Health's Cash from Financing Activities stood at -$14.8 million in 2022, then jumped by 73.47% to -$3.9 million in 2023, then grew by 23.72% to -$3.0 million in 2024, then tumbled by 1433.52% to -$45.8 million in 2025, then fell by 8.21% to -$49.5 million in 2026.
• Business Quant data shows NUTX's Cash from Financing Activities at -$49.5 million in Q1 2026, -$45.8 million in Q4 2025, and -$29.9 million in Q3 2025.